ID   KU-CTCC-001
AC   CVCL_E5T0
SY   Konkuk University-Canine Transitional Cell Carcinoma-001
DR   ABM; T8165
RX   PubMed=34502061;
CC   Doubling time: 17.7 +- 1.2 hours (PubMed=34502061).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Unspecified (PubMed=34502061).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Urethra; UBERON=UBERON_0000057.
CC   Breed/subspecies: Jindo; VBO=VBO_0008065.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_E5T1 ! KU-CTCC-001-LM3
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=34502061; DOI=10.3390/ijms22179151; PMCID=PMC8430554;
RA   Jung H., Bae K., Lee J.Y., Kim J.-H., Han H.-J., Yoon H.-Y., Yoon K.-A.;
RT   "Establishment of canine transitional cell carcinoma cell lines
RT   harboring BRAF V595E mutation as a therapeutic target.";
RL   Int. J. Mol. Sci. 22:9151.1-9151.15(2021).
//